363 related articles for article (PubMed ID: 28550479)
1. Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.
Meola G; Biasini F; Valaperta R; Costa E; Cardani R
J Neurol; 2017 Aug; 264(8):1705-1714. PubMed ID: 28550479
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
3. Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.
Meola G; Cardani R
Neurol Sci; 2017 Apr; 38(4):535-546. PubMed ID: 28078562
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic odyssey of patients with myotonic dystrophy.
Hilbert JE; Ashizawa T; Day JW; Luebbe EA; Martens WB; McDermott MP; Tawil R; Thornton CA; Moxley RT
J Neurol; 2013 Oct; 260(10):2497-504. PubMed ID: 23807151
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
Valaperta R; Lombardi F; Cardani R; Fossati B; Brigonzi E; Merli I; Sansone V; Merletti G; Spina E; Meola G; Costa E
Genet Test Mol Biomarkers; 2015 Dec; 19(12):703-9. PubMed ID: 26505324
[TBL] [Abstract][Full Text] [Related]
6. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
7. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
Meola G; Cardani R
Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
[TBL] [Abstract][Full Text] [Related]
8. Myotonic dystrophy type 2: the 2020 update.
Meola G
Acta Myol; 2020 Dec; 39(4):222-234. PubMed ID: 33458578
[TBL] [Abstract][Full Text] [Related]
9. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
Finsterer J; Rudnik-Schöneborn S
Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
[TBL] [Abstract][Full Text] [Related]
10. The myotonic dystrophies: diagnosis and management.
Turner C; Hilton-Jones D
J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):358-67. PubMed ID: 20176601
[TBL] [Abstract][Full Text] [Related]
11. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
[TBL] [Abstract][Full Text] [Related]
12. Myotonic dystrophy: from bench to bedside.
Johnson NE; Heatwole CR
Semin Neurol; 2012 Jul; 32(3):246-54. PubMed ID: 23117949
[TBL] [Abstract][Full Text] [Related]
13. A Greek National Cross-Sectional Study on Myotonic Dystrophies.
Papadimas GK; Papadopoulos C; Kekou K; Kartanou C; Kladi A; Nitsa E; Sofocleous C; Tsanou E; Sarmas I; Kaninia S; Chroni E; Tsivgoulis G; Kimiskidis V; Arnaoutoglou M; Stefanis L; Panas M; Koutsis G; Karadima G; Traeger-Synodinos J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555146
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular aspects of the myotonic dystrophies: a review.
Machuca-Tzili L; Brook D; Hilton-Jones D
Muscle Nerve; 2005 Jul; 32(1):1-18. PubMed ID: 15770660
[TBL] [Abstract][Full Text] [Related]
15. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
16. The current clinical perception of myotonic dystrophy type 2.
Kleefeld F; Schoser B
Curr Opin Neurol; 2023 Oct; 36(5):474-478. PubMed ID: 37639480
[TBL] [Abstract][Full Text] [Related]
17. Myotonic dystrophies type 1 and 2: anesthetic care.
Veyckemans F; Scholtes JL
Paediatr Anaesth; 2013 Sep; 23(9):794-803. PubMed ID: 23384336
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic heterogeneity in myotonic dystrophies.
Meola G
Muscle Nerve; 2000 Dec; 23(12):1789-99. PubMed ID: 11102902
[TBL] [Abstract][Full Text] [Related]
19. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.
Cardani R; Mancinelli E; Sansone V; Rotondo G; Meola G
Eur J Histochem; 2004; 48(4):437-42. PubMed ID: 15718211
[TBL] [Abstract][Full Text] [Related]
20. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 and DM2).
Gawel M; Szmidt-Salkowska E; Lusakowska A; Nojszewska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
Muscle Nerve; 2014 Feb; 49(2):277-83. PubMed ID: 23716346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
